Altimmune Inc (ALT)
7.26
+0.06
(+0.83%)
USD |
NASDAQ |
Apr 26, 16:00
7.26
0.00 (0.00%)
After-Hours: 20:00
Altimmune Free Cash Flow (Quarterly): -16.53M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.53M |
| September 30, 2023 | -20.49M |
| June 30, 2023 | -19.38M |
| March 31, 2023 | -19.46M |
| December 31, 2022 | -17.34M |
| September 30, 2022 | -15.11M |
| June 30, 2022 | -16.72M |
| March 31, 2022 | -13.54M |
| December 31, 2021 | -22.12M |
| September 30, 2021 | -17.89M |
| June 30, 2021 | -26.70M |
| March 31, 2021 | -23.84M |
| December 31, 2020 | -13.43M |
| September 30, 2020 | -9.584M |
| June 30, 2020 | -7.253M |
| March 31, 2020 | -4.385M |
| December 31, 2019 | -2.004M |
| September 30, 2019 | -2.436M |
| June 30, 2019 | -3.073M |
| March 31, 2019 | -2.117M |
| December 31, 2018 | -5.164M |
| September 30, 2018 | -1.191M |
| June 30, 2018 | 0.1765M |
| March 31, 2018 | -4.226M |
| December 31, 2017 | -4.835M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.282M |
| June 30, 2017 | -7.864M |
| March 31, 2017 | -3.400M |
| December 31, 2016 | -1.534M |
| September 30, 2016 | -2.013M |
| June 30, 2016 | -1.671M |
| March 31, 2016 | -1.355M |
| December 31, 2015 | -1.847M |
| September 30, 2015 | -1.339M |
| June 30, 2015 | 2.632M |
| March 31, 2015 | -2.749M |
| December 31, 2014 | -3.522M |
| September 30, 2014 | -2.137M |
| June 30, 2014 | -0.5755M |
| March 31, 2014 | -2.331M |
| December 31, 2013 | -6.256M |
| September 30, 2013 | -0.6907M |
| June 30, 2013 | -0.5405M |
| March 31, 2013 | 0.2349M |
| December 31, 2012 | -2.145M |
| September 30, 2012 | 1.734M |
| June 30, 2012 | -2.704M |
| March 31, 2012 | 0.7914M |
| December 31, 2011 | -0.8051M |
| September 30, 2011 | -3.659M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-26.70M
Minimum
Jun 2021
-2.004M
Maximum
Dec 2019
-14.28M
Average
-16.53M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | -1.963B |
| Amgen Inc | 289.00M |
| Pfizer Inc | 4.196B |
| Viking Therapeutics Inc | -6.134M |
| Precision BioSciences Inc | -8.418M |